Evidation
PrivateLast Round
Series E
Mar 22, 2021
Est. Valuation
$1B
Total Funding Raised
$259.2M
Company Overview
Evidation operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Series E round in March 2021.
Evidation is a health technology company that provides a data analytics platform to collect and analyze continuous behavior data and healthcare information for improved health insights and outcomes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Patient Engagement, Data Integration
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evidation Comparables
Compare Evidation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Truveta | 79% | |
| Koneksa Health | 79% | |
| PicnicHealth | 78% |
For institutional investors. Book with your work email.
Evidation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Mar 22, 2021 | ||||
| Series D | Jul 1, 2020 | ||||
| Series C | Aug 1, 2018 | ||||
| Series B Extension | Apr 27, 2017 | ||||
| Series B | Oct 11, 2016 | ||||
Series A | Jan 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evidation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series D |
| Rock Health | Series A |
| Fresco Capital | Series B |
| OMERS | Series E |
| SV Health Investors | Series D, Series C |
| A. M. Pappas & Associates | Series B |
| Kaiser Permanente Ventures | Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
Added Jazz Pharmaceuticals, Inc. from the Pharmaceuticals industry.
- May 7, 2026
Added Genentech, a biotechnology/pharmaceuticals company, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 12, 2026
Evidation shares more about its autoimmune research platform during Fierce Biotech at London Life Sciences Week on Nov 17th '26 in the United Kingdom, where Chief Medical Officer Sunny Khan, MPH, MBChB, MRCGP, speaks.
- attends_eventNov 12, 2026
Evidation is scheduled to share more about its autoimmune research platform during Fierce Biotech at London Life Sciences Week in United Kingdom on Nov 17th '26, where its chief medical officer speaks.
For institutional investors. Book with your work email.
Evidation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evidation's valuation, stock price, and market status.
Is Evidation a public or private company?
Evidation is a private company.
What is the current stock price of Evidation?
Evidation is a private company, so its shares have no public market price. Caplight tracks Evidation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evidation worth (valuation)?
Evidation's valuation is estimated at $1.0B based on funding round data.
Can I buy Evidation stock?
Evidation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evidation's last funding round?
Evidation's most recent funding round was Series E on March 22, 2021.
Who are the main investors in Evidation?
Key investors in Evidation include OMERS, SV Health Investors, B Capital Group, OMERS Growth Equity, General Electric Ventures.
Will Evidation IPO soon?
No public IPO plans have been announced for Evidation.
How can I track Evidation secondary market activity?
Caplight tracks bids, offers, and trades in Evidation's shares on secondary markets.